Benign symmetric lipomatosis associated with protease inhibitors

Lancet

Volumn 350, Issue 9091, 1997, Pages 1596-

  Hengel, R L ^a   Watts, N B ^a   Lennox, J L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIFAMOLE; DEXAMETHASONE; INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; SULFAMETHOXAZOLE; TRIMETHOPRIM; ZIDOVUDINE;

ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPID STORAGE; LIPOMATOSIS; PRIORITY JOURNAL;

EID: 0031556850     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)64011-1     Document Type: Article

References (5)

1. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 counts of 200 per cubic millimeter or less. N Engl J Med 1997; 337: 725-33.
2. Deeks SG, Smith M, Holodniy M, et al. HIV-1 protease inhibitors: a review for clinicians. JAMA 1997; 277: 145-53.
3. Dube MP, Johnson DL, Currier JS. Protease inhibitor-associated hyperglycemia. Lancet 1997; 350: 713.
4. Ruzicka T, Vieluf D, Landthaler M, et al. Benign symmetric lipomatosis Launois-Bensaude. Report of ten cases and review of the literature. J Amer Acad Derm 1987; 17: 663-74.
5. Enzi G, Favaretto S, Martini R, et al. Metabolic abnormalities in multiple symmetric lipomatosis: elevated lipoprotein lipase activity in adipose tissue with hyperalphalipoproteinemia. J Lipid Res 1983; 24: 566-74.